Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T19:24:35.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.9%
    Check dated 2025-01-12T16:14:19.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:33:22.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T10:50:19.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The website has removed a detailed section regarding data download options and study information fields, which may affect users looking for specific data formats and study details.
    Difference
    13%
    Check dated 2024-11-23T04:24:38.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    New content was added on November 14, 2024, while previous content was removed on February 23, 2024.
    Difference
    0.5%
    Check dated 2024-11-15T22:52:28.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.